Short title

This Act may be cited as the

Biological Implant Tracking and Veteran Safety Act of 2014

Identification and tracking of biological implants used in Department of Veterans Affairs medical facilities

(a)

In general

Subchapter II of chapter 73 of title 38, United States Code, is amended by adding at the end the following new section:

7330B.

Identification and tracking of biological implants

(a)

Standard identification system for biological implants

The Secretary shall adopt the unique device identification system developed for medical devices by the Food and Drug Administration pursuant to section 519(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360i(f)), or implement a comparable standard identification system, for use in identifying biological implants intended for use in medical procedures conducted in medical facilities of the Department. (b)

Biological implant tracking system

(1)The Secretary shall implement a system for tracking the biological implants referred to in subsection (a) from donor to implantation. Such system shall be compatible with the identification system adopted or implemented under subsection (a). (2)The Secretary shall implement inventory controls compatible with the tracking system implemented under paragraph (1) so that all patients who have received, in a medical facility of the Department, a biological implant subject to a recall by the Food and Drug Administration can be notified of the recall, if based on the evaluation of appropriate medical personnel of the Department of the risks and benefits, the Secretary determines such notification is appropriate. (c)

Consistency with Food and Drug Administration regulations

To the extent that a conflict arises between this section and a provision of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) or sections 351 or 361 of the Public Health Service Act (42 U.S.C. 262) (including any regulations issued under such Acts), the provision the Federal Food, Drug, and Cosmetic Act or Public Health Service Act (including any regulations issued under such Acts) shall apply. (d)

Definition of biological implant

In this section, the term biological implant means any human cell, tissue, or cellular or tissue-based product— (1)under the meaning given the term human cells in section 1271.3 of title 21, Code of Federal Regulations, or any successor regulation; or (2)that is regulated as a device under subpart A of part 801 of title 21, Code of Federal Regulations, or any successor regulation.

(b)

Clerical amendment

The table of sections at the beginning of such chapter is amended by adding at the end of the items relating to such subchapter the following new item:

7330B. Identification and tracking of biological implants.

(c)

Implementation deadlines

(1)

Standard identification system

(A)

In general

With respect to biological implants described in paragraph (1) of subsection (d) of section 7330B of title 38, United States Code, as added by subsection (a), the Secretary of Veterans Affairs shall adopt or implement a standard identification system for biological implants, as required by subsection (a) of such section, by not later than the date that is 180 days after the date of the enactment of this Act. (B)

Implants regulated as devices

With respect to biological implants described in paragraph (2) of subsection (d) of such section, the Secretary of Veterans Affairs shall adopt or implement such standard identification system in compliance with the compliance dates established by the Food and Drug Administration pursuant to section 519(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360i(f)). (2)

Tracking system

The Secretary of Veterans Affairs shall implement the biological implant tracking system required by subsection (b) of section 7330B, as added by subsection (a), by not later than the date that is 180 days after the date of the enactment of this Act. (d)

Reporting requirement

If the biological implant tracking system required by subsection (b) of such section is not operational by the date that is 180 days after the date of the enactment of this Act, the Secretary of Veterans Affairs shall provide to the Committees on Veterans’ Affairs of the Senate and House of Representatives a written explanation for each month until such time as the system is operational. Each such explanation shall describe each impediment to the implementation of the system, steps being taken to remediate each such impediment, and target dates for a solution to each such impediment.

Procurement of biological implants used in Department of Veterans Affairs medical facilities

(a)

Procurement

(1)

In general

Subchapter II of chapter 81 of such title is amended by adding at the end the following new section:

8129.

Procurement of biological implants

(a)

In general

(1)The Secretary may procure biological implants only from vendors that meet the following conditions: (A)The vendor uses the standard identification system adopted or implemented by the Secretary under section 7330B(a) of this title and has safeguards to ensure that a production identifier has been in place at each step of distribution of each biological implant from its donor. (B)The vendor is registered with the Food and Drug Administration under subpart B of part 1271 of title 21, Code of Federal Regulations, or any successor regulation, and in the case of a vendor that uses tissue distribution intermediaries, the vendor uses only tissue distribution intermediaries that are appropriately registered with the Food and Drug Administration. (C)The vendor ensures that donor eligibility determinations and such other records as the Secretary may require accompany each biological implant at all times, regardless of the country of origin of the donor of the biological material. (D)The vendor consents to periodic inspections and audits by the Department of Veterans Affairs regarding the accuracy of records and the handling of products. (E)The vendor agrees to cooperate with all biological implant recalls conducted on the vendor’s own initiative, by the request of the Food and Drug Administration, or by a statutory order of the Food and Drug Administration. (F)The vendor agrees to provide to the Secretary any adverse event report or warning letter of the Food and Drug Administration issued to the vendor by not later than 30 days after the vendor receives such report or warning letter. (G)The vendor agrees to retain all records associated with the procurement of a biological implant by the Department for at least five years after the date of the procurement of the biological implant. (H)The vendor maintains active accreditation with the American Association of Tissue Banks or a similar national accreditation specific to biological implants. (2)The Secretary shall procure biological implants under the Federal Supply Schedules of the General Services Administration, unless such implants are not available under such Schedules. For biological implants listed on the Federal Supply Schedules, the Secretary shall accommodate reasonable vendor requests to undertake outreach efforts to educate medical professionals of the Department about the use and efficacy of such biological implants. (3)Section 8123 of this title shall not apply to the procurement of biological implants. (4)In the case of biological implants that are unavailable for procurement under the Federal Supply Schedules, the Secretary shall procure such implants using competitive procedures in accordance with applicable law and the Federal Acquisition Regulation. (b)

Penalties

In addition to any applicable penalty under any other provision of law, any procurement employee of the Department who is found responsible for a biological implant procurement transaction with intent to avoid or with reckless disregard of the requirements of this section shall be ineligible to hold a certificate of appointment as a contracting officer or to serve as the representative of an ordering officer, contracting officer, or purchase card holder. (c)

Definitions

In this section: (1)The term biological implant shall have the meaning given such term in section 7330B(d) of this title. (2)The term production identifier means a distinct identification code that— (A)relates a biological implant to the donor of the implant and to all records pertaining to the implant; (B)includes information designed to facilitate effective tracking, using the distinct identification code, from the donor to the recipient and from the recipient to the donor; and (C)satisfies the requirements of subsection (c) of section 1271.290 of title 21, Code of Federal Regulations, or any successor regulation.

(2)

Clerical amendment

The table of sections at the beginning of such chapter is amended by adding at the end of the items relating to such subchapter the following new item:

8129. Procurement of biological implants.

(b)

Effective date

Section 8129 of title 38, United States Code, as added by subsection (a), shall take effect on the date that is 180 days after the date on which the tracking system required under subsection (b) of section 7330B of such title, as added by section 2(a) is implemented. (c)

Special rule for cryopreserved products

During the three-year period beginning on the effective date of section 8129 of title 38, United States Code, as added by subsection (a), biological implants produced and labeled before that date may be procured by the Department of Veterans Affairs without relabeling under the standard identification system adopted or implemented under section 7330B of such title, as added by section 2(a).